Obstructive uropathy

Current Opinion in Urology

Volumn 8, Issue 2, 1998, Pages 119-124

  Young, Leonie S ^a   Hegarty, Nicholas J ^a   Fitzpatrick, John M ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FUNCTION; CLINICAL PRACTICE; HUMAN; MEDIATOR; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; REVIEW; TECHNIQUE; VASODILATATION;

EID: 0031884307     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199803000-00009     Document Type: Review

References (50)

1. Bagley DH. Intrarenal access with the flexible ureteropyeloscope. Effects of active and passive tip deflection. J Endourol 1993; 7:221-224.
2. Conlin MJ, Marberger M, Bagley DH. Urteroscopy development and instrumentation. Ural Clin North Am 1997; 24:25-42.
3. Harmon WJ, Sershon P, Blute ML, Patterson DE, Segura JW. Ureteroscopy: current practice and complications. J Urol 1997; 157:28-32.
4. Allen J, Vaughan E, Gillenwater J. The effect of indomethacin on renal blood flow and ureteral pressure in unilateral ureteral obstruction in awake dogs. Invest Urol 1978; 15:324.
5. Lanzone J, Gulmi F, Chou S, Mooppan U, Kim H. Renal hemodynamics in acute unilateral ureteral obstruction: contribution of endothelium-derived relaxing factor. J Urol 1995; 153:2055-2059.
6. Shulsinger D, Gulmi F, Chou S-Y, Mooppan U, Kim H. Activation of the endothelium-derived relaxing factor system in acute unilateral ureteral obstruction. J Urol 1997; 157:1951-1956. A comprehensive paper dealing with the L-arginine-NO pathway in renal vasodilation during UUO.
7. Ichikawa I, Harris R. Angiotensin actions in the kidney renewed insight into the old hormone. Kidney Int 1991; 40:583-596.
8. Frokiaer J, Marples D, Knepper M, Nielsen S. Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP-2 water channel in rat kidney. Am J Physiol 1996; 270:F657-F668.
9. Frokiaer J, Djurhuus J, Neilsen M, Pedersen E. Renal haemodynamic response to ureteral obstruction during converting enzyme inhibition. Urol Res 1996; 24:217-227.
10. Kahn S, Gulmi F, Chou S-Y, Mooppan U, Kim H. Contribution of endothelin-1 to renal vasoconstriction in unilateral ureteral obstruction: reversal by verapamil. J Urol 1997; 157:1957-1962.
11. Stief C, Uckert S, Truss M, Becker A, Machtens S, Joans U. A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone. Urol Res 1996; 24:333-337.
12. Frokiaer J, Christensen B, Marples D, Djurhuus J, Jensen U, Knepper M. Downregulation of aquaporin-2 parallels changes in renal water excretion in unilateral ureteral obstruction. Am J Physiol 1997; 273:F213-F223. An elegant study demonstrating a downregulation in the vasopressin-regulated water channel, aquaporin-2, of the kidney collecting duct after UUO.
13. Truong L, Petrusevska G, Yang G, Gurpinar T, Shappell S, Lechago J, et al. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 1996; 50:200-207.
14. Morrissey J, Ishidoya S, McCracken R, Klahr S. Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction. Kidney Int 1996; 57:84-92. An indepth analysis of growth factors and cell-cycle related genes expressed after UUO.
15. Ricardo S, Levinson M, DeJoseph M, Diamond J. Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 1996; 50:2002-2010.
16. Diamond J, Levinson M, Kreisberg R, Ricardo D. Increased expression of decorin in experimental hydronephrosis. Kidney Int 1997; 51:1133-1139.
17. Medjebeur A, Bussieres L, Gasser B, Gimonet V, Laborde K. Experimental bilateral urinary obstruction in fetal sheep: transforming growth factor β1 expression. Am J Physiol 1997; 273:F372-F379.
18. Shokeir A, Provoost A, Nijman R. Resistive index in obstructive uropathy. Br J Urol 1997; 80:195-200.
19. Cole T, Brock J, Pope J, Schrum F. Evaluation of renal resistive index, maximum velocity, and mean arterial flow velocity in a hydronephrotic partially obstructed pig model. Invest Radiol 1997; 32:154-160.
20. Shokeir A, Nijman H. Partial ureteral obstruction: role of renal resistive index in stages of obstruction and release. Urology 1997; 49:528-535.
21. Brooks JD, Kavoussi LR, Preminger GM, Schuessler WW. Comparison of open and endourologic approaches to the obstructed ureteropelvic junction. Urology 1995; 46:791-795.
22. Wickham JEA, Kellett MJ. Percutaneous pyelolysis. Eur Urol 1983; 9:122-124.
23. Motola JA, Badlani GH, Smith AD. Results of 212 consecutive endopyelotomies: an 8-year follow-up. J Urol 1993; 149:453-456.
24. Sherbume Figenshau R, Clayman RV, Colberg JW, Coplen DE, Soble JJ, Manley CB. Pediatric endopyelotomy: the Washington University experience. J Urol 1996; 156:2025-2030.
25. Van Cangh PJ. Editorial comment. J Urol 1997; 157:1618-1619.
26. Gupta M, Tuncay OL, Smith AD. Open surgical exploration after failed endopyelotomy: a 12-year perspective. J Urol 1997; 157:1613-1619.
27. Van Cangh PJ, Nesa S, Galeon M, Tambol B, Wese F, Dardene AN, et al. Vessels around the ureteropelvic junction: significance and imaging by conventional radiology. J Endourol 1996; 10:111-119.
28. Cohen TD, Gross MB, Preminger GM. Long-term follow-up of Acucise incision of ureteropelvic junction obstruction and ureteral strictures. Urology 1996; 47:317-323.
29. Siegel CL, McDougall EM, Middleton WD, Brink JA, Quillin SP, Teefey SA, et al. Preoperative assessment of ureteropelvic junction obstruction with endoluminal sonography and helical CT. AJR 1997; 168:623-626. Detailed images of the immediate ureteral surroundings can now be obtained at ureteroscopy as an aid to diagnosis and planning of surgery to surgery.
30. Bagley DH, Conlin MJ, Liu JB. Device for intraluminal incision guided by endoluminal ultrasonography. J Endourol 1996; 10:421-423.
31. Thomas R, Cherry R. Ureteroscopic retrograde endopyelotomy for the management of ureteropelvic junction obstruction. J Endourol 1990; 45:141-146.
32. Meretyk I, Meretyk S, Clayman RV. Endopyelotomy comparison of ureteroscopic retrograde and antegrade percutaneous techniques. J Urol 1992; 148:775-783.
33. Nadler RB, Rao GS, Pearle MS, Nakada SY, Clayman RV. Acucise endopyelotomy: assessment of longterm durability. J Urol 1996; 156:1094-1098. Early success rates observed after endopyelotomy in adults appear to be sustained with long-term follow-up.
34. Faerber GJ, Richardson TD, Farah N, Ohl DA. Retrograde treatment of uretropelvic junction obstruction using the ureteral cutting balloon catheter. J Urol 1997; 157:454-458.
35. Moore RG, Averch TD, Schulam PG, Adams JB, Chen RN, Kavoussi LR. Laparoscopic pyeloplasty: experience with the initial 30 cases. J Urol 1997; 157:459-462. Dismembered pyeloplasty can now be performed laparoscopically and, in completed cases, is likely to have similar long-term success rates to open surgery.
36. Eden CG. Operative retroperitoneoscopy. Br J Urol 1995; 76:125-130.
37. Puppo P, Perachino M, Ricciotti G, Bozzo W, Pezzica C. Retroperitoneoscopic treatment of ureteropelvic junction obstruction. Eur Urol 1997; 31:204-208.
38. Eden CG, Sultana SR, Murray KHA, Carruthers RK. Retroperitoneoscopic dismembered fibrin-glued pyeloplasty. Br J Urol 1997; 80:382-389.
39. Janetschek G, Peschel R, Altarac S, Bartsch G. Laparoscopic and retroperitoneoscopic repair of ureteropelvic junction obstruction. Urology 1996; 47:311-316.
40. Goldfischer ER, Gerber GS. Endoscopic management of ureteral stricture. J Urol 1997; 157:770-775. This study provides a comprehensive overview of the ureteroscopic options to open surgical correction.
41. Kwok PCH, Cheung JYL. A radiological approach to the through and through technique for percutaneous passage of ureteric strictures. Clin Radiol 1996; 51:879-891. The range of strictures amenable to fluoroscopic treatment continues to expand with improvements in equipment and technique.
42. Barbalias GA, Siablis D, Liatsikos EN, Karnabatidis D, Yarmenitis S, Bouropoulos K, Dimopoulos J. Metal stents: a new treatment of malignant ureteral obstruction. J Urol 1997; 158:54-58. Early reports on stenting show that it requires considerable vigilance, but that it can have an impact on the treatment of these difficult strictures.
43. Lopez-Martinez RA, Singireddy S, Lang EK. The use of metallic stents to bypass ureteral strictures secondary to metastatic prostate cancer: experience with 8 patients. J Urol 1997; 158:50-53.
44. Bierkens AF, Oosterhof GO, Meuleman EJ, Debruyne FM. Anterograde percutaneous treatment of ureterointestinal strictures following urinary diversion. Eur Urol 1996; 30:363-368.
45. Kablain JN. Acucise incision of ureteroenteric strictures after urinary diversion. J Endourol 1997; 11:37-40.
46. Pleass HCC, Clark KR, Rigg KM, Reddy KS, Forsythe JL, Proud G. Taylor RM. Urologic complications after renal transplantation: a prospective randomized trial comparing different techniques of ureteric anastomosis and the use of prophylactic stents. Transplant Proc 1995; 27:1091-1092.
47. Butterworth PC, Horsburgh T, Veitch PS, Bell PRF, Nicholson ML. Urologic complications in renal transplantation: impact of a change of technique. Br J Urol 1997; 79:499-502.
48. Ehrlich RM, Freedman A. Surgical treatment of long ureteral defects. AUA Update Series 1985; 4:Lesson 22.
49. Shokier AA. Interposition of ileum in the ureter: a clinical study with long-term follow-up. Br J Urol 1996; 79:324-327.
50. Sabanegh ES Jr, Downey JR, Sago AL. Long-segment ureteral replacement with expanded polytetrafluoroethylene grafts. Urology 1996; 48:312-316.